prmaconsulting™
Pricing, reimbursement and market access consulting
Licensing & Acquisitions
prmaconsulting™ undertakes pricing and reimbursement due diligence.
In-Licensing
Ensure that all the pricing, reimbursement and market access risks have been assessed.
- What is the value proposition of this product?
- Is the product reimbursable?
- What is a realistic target price?
- What is the size of the reimbursed population?
- How long will it take to access the market?
- What are the chances of undergoing a successful HTA?
- Will reference pricing impact this product?
Out-Licensing
Ensure the right questions are asked at the right time to extract the maximum product value.
- Are there any pricing and reimbursement surprises in store as this product is out-licensed?
- Does the internal valuation reflect the pricing and reimbursement challenge/opportunity?
- Have the right questions been asked to demonstrate the value of the product early enough?
- What is the value proposition and what does this mean for deal value?
VC and PE
prmaconsulting™ helps Venture Capital and Private Equity companies to undertake due diligence around the risks associated with investment opportunities.
- What price will this technology command at launch?
- How will it be reimbursed?
- Is additional investment needed to support the product’s value and achieve a better price?
prmaconsulting™ assists
portfolio companies to develop pricing
and reimbursement and health outcomes strategies to deliver maximum product value.
Fill in the fields below and press submit. A member of our team
will respond
shortly.
Email: info@prmaconsulting.com
Tel: +44 (0) 1252 786284
Head Office
PRMA Consulting, Centaur House, Ancells Road, Fleet, GU51 2UJ
prmaconsulting™